Why does this page look this way?
It appears that you are using either an older, classic Web browser or a hand-held device that allows you to view our content but may not work with every feature of our site. If you are using an older browser, please upgrade for the best experience.
Navigation
home > by publication type > op-eds > A Delicate Balance
| Author: | Michael J. Gerson, Roger Hertog Senior Fellow |
|---|
September 4, 2006
Newsweek
The issue of stem cells was the first test of the infant Bush administration, pitting the promise of medical discovery against the protection of developing life and prompting the president’s first speech to the nation. His solution—funding research on existing stem-cell lines, but not the destruction of embryos to create new ones—was seen as a smart political compromise. In fact, the president was drawing a bright ethical line. He argued that no human life should be risked or destroyed for the medical benefit of another. This was an intentional rejection of the chilly creed of utilitarianism—the greatest good for the greatest number—because the greatest number would gain the unrestricted right to extend their lives by ending or exploiting the lives of the weak.
Now the suggestion that science may be able to extract usable stem cells from early embryos without destroying them offers a technological answer to this ethical puzzle, and exposes some tensions within the pro-life movement.
In the reported experiment, every embryo was killed to extract their stem cells, a fact not likely to encourage enthusiasm in the pro-life community. But the growth of viable stem-cell lines from very early cells raises the prospect that these cells could be collected in more ethical ways, through existing fertility technologies that test for disease without ending a life. This method, as it stands, is still questionable, but it is testable.
To order Task Force reports, Council Special Reports, and Critical Policy Choices, please call, fax, or order online from our distributor, the Brookings Institution Press: phone +1.800.537.5487, fax +1.410.516.6998.
For information on other reports that are not for sale, or for general publications information, please call +1.212.434.9516 or email publications@cfr.org.
Start-Up Nation addresses the trillion-dollar question: How is it that Israel—a country of 7.1 million, only sixty years old, surrounded by enemies— produces more start-up companies than large, peaceful, and stable nations like Japan, China, India, Korea, Canada, and the UK? With the insights of geopolitical experts and investors, the authors examine this nation’s adversity-driven culture to answer this question and offer prescriptions for a global economy on the rebound.
In Forces of Fortune, Vali Nasr presents a paradigm-changing revelation that will transform the understanding of the Muslim world at large. He reveals that there is a vital but unseen rising force in the Islamic world—a new business-minded middle class—that is building a vibrant new Muslim world economy and that holds the key to winning the cold war against Iran and extremists.
In Cuba: What Everyone Needs to Know, Julia E. Sweig presents a remarkably accessible portrait of Cuba's unique place on the world stage over the past fifty years, including its internal politics, its often fraught relationship with the United States, and its shifting relationship with the global community.
Complete list of CFR Books
Browse Content By Region IssuePublication TypeThe Think TankFor The MediaFor Educators About CFR
Copyright 2009 by the Council on Foreign Relations. All Rights Reserved.
